MedTrace Logo

The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

NCT04132479 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 313

Last updated 2019-10-18

No results posted yet for this study

Summary

This study aims to:

1. Determine the prevalence of Helicobacter infection in Myanmar (this would be the largest ever series in the country)
2. Determine the clinical and epidemiological associations of Helicobacter infection in Myanmar
3. Determine the utility of stool antigen testing to diagnose the infection and confirm eradication
4. Compare the relative efficacies of concomitant and sequential therapy
5. Determine the relative efficacies of first, second and third line therapies in Myanmar in 2018

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Clarithromycin 500mg

1000mg taken orally every 12 hours for 5 days

DRUG

Amoxicillin 500mg

1000mg taken orally every 12 hours for 5 days

DRUG

Tinidazole 500mg

500mg taken orally every 12 hours for 5 days

DRUG

Rabeprazole 20mg

20mg taken orally every 12 hours for 5 days

DRUG

Clarithromycin 500mg

1000mg taken orally every 12 hours for 14 days

DRUG

Amoxicillin 500mg

1000mg taken orally every 12 hours for 14 days

DRUG

Tinidazole 500mg

500mg taken orally every 12 hours for 14 days

DRUG

Rabeprazole 20mg

20mg taken orally every 12 hours for 14 days

Sponsors & Collaborators

  • University of Medicine 2, Yangon, Myanmar

    collaborator UNKNOWN

  • Kirby Institute

    lead OTHER_GOV

Principal Investigators

  • Mar Mar Kyi, MD · University of Medicine 2, Yangon, Myanmar

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-31
Completion
2019-04-09

Countries

  • Burma

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04132479 on ClinicalTrials.gov